Age-related macular degeneration (AMD) is a late-onset, neurodegenerative disease that causes visual impairment and blindness in the elderly population.1 Multiple genetic loci have been identified as contributing to AMD, including complement pathway-related genes (CFH,2, 3, 4 C2-CFB,5 C3,6, 7 CFI8), lipoprotein metabolism-related genes (APOE,9, 10, 11 LIPC,12 TIMP313) and additional loci such as VEGFA14 and ARMS2/HTRA1.15, 16 Fagerness et al8 initially reported the complement factor I (CFI) gene region associated with AMD in a Caucasian cohort (1228 cases and 825 controls), with the rs10033900 variant located in a downstream region near the CFI gene showing the most significant signal (P=6.46 × 10−8). This association signal was also confirmed by meta-analysis in a genome-wide association study (2594 cases and 4134 controls) with follow-up replication (5640 cases and 52174 controls) in the largest sample of individuals with European ancestry (P=4.1 × 10−10).14 In addition, the C allele of rs10033900 has been commonly identified as a protective allele against AMD in genetic studies.8, 14, 17, 18 However, there remains debate as to whether rs10033900 contributes to AMD susceptibility, due to contradicting evidence published in this journal.18, 19, 20 For example, Ennis et al20 confirmed the association between the CFI region and AMD susceptibility in a UK cohort, although rs10033900 showed no association with AMD. Kondo et al18 demonstrated the association of rs10033900 with the C allele in a Japanese cohort, showing the same association direction as the results of Fagerness et al.8 In contrast, Cipriani et al19 observed no association between rs10033900 and AMD in a study of two independent cohorts from England and Scotland. To investigate the reported association of rs10033900 in the Han Chinese population, we studied this locus in our cohort of 288 unrelated AMD patients and 384 healthy controls.
Standard informed consent was obtained from all participants. A demographic summary of the phenotypic information is shown in Table 1. High-molecular-weight genomic DNA was prepared from venous blood using standard phenol-chloroform extraction. The variant of interest was genotyped using a TaqMan SNP genotyping assay (Life Technologies, Carlsbad, CA, USA) by laboratory personnel blinded to the sample status. This variant was in Hardy–Weinberg equilibrium among controls (P=0.08). We also evaluated the association between alleles and AMD in terms of odds ratios (ORs), 95% confidence intervals (CIs) and corresponding P-values based on Fisher’s exact test. We further evaluated the association between genotypes and AMD using logistic regression applied in three different statistic models: an additive model, dominant model and recessive model. In the additive model, homozygotes with two risk alleles were coded as 2, while heterozygotes with one risk allele were coded as 1 and homozygotes with non-risk alleles were coded as 0. In the dominant model, either homozygotes or heterozygotes with risk alleles were coded as 1, while homozygotes with non-risk alleles were coded as 0. In the recessive model, only homozygotes with two risk alleles were coded as 1, so both homozygotes and heterozygotes with non-risk alleles were coded as 0. Akaike’s information criterion (AIC) values were calculated for each model, and the model with lowest AIC was considered the best-fitting model. All of the statistical tests were carried out using the R software package (http://www.r-project.org/), and a P-value<0.05 was defined as statistical significance. Statistic power was calculated using the G*Power program.21
Our results replicated the association between rs10033900 and AMD (OR, 1.33; 95% CI, 1.04–1.69; P=0.021) in the Han Chinese population. We found genotypic associations both in the additive model (OR, 1.30; 95% CI, 1.03–1.63; P=0.025) and dominant model (OR, 1.42; 95% CI, 1.03–1.97; P=0.033). The results of a previous Japanese study18 were in favor of the recessive model (P=0.0035 compared with P=0.036 in the additive model), whereas in our study, the additive model was found to be the best-fitting model of inheritance with the lowest AIC among the three models (Table 2). Furthermore, our study was well-powered because the current sample size demonstrated >90% statistical power to detect association significance (OR, 1.33). Interestingly, we observed that the minor allele, that is, the C allele, conferred an increased risk for the development of AMD, whereas a decreased risk of such an association with AMD was reported in previous studies.8, 17, 18, 20 In particular, a recent Chinese study (119 exudative AMD patients and 120 controls) also reported a protective effect of rs10033900 against AMD.22 However, we believe our result is reliable because the frequency of the C allele in our controls was 0.324, which is close to the frequency of 0.328 reported for CHB (Han Chinese in Beijing, China) from the HapMap project (http://hapmap.ncbi.nlm.nih.gov/). Moreover, the use of controls from this Chinese study with a C allele frequency of 0.29322 indicated a higher risk effect for AMD (OR, 1.53; 95% CI, 1.11–2.13; P=0.008). Although Wu et al22 focused on exudative AMD samples and we used overall AMD samples, we do not believe that the subtypes of AMD in our study caused the observed difference in the effective direction, as the frequencies of the C allele were very close between different subtypes (0.387 in geographic atrophy, 0.381 in choroidal neovascularization and 0.395 in cases diagnosed with AMD but without further subtype information) and were all higher than the frequencies observed in control groups (0.293–0.328). In the European population, the C allele is a major allele with a frequency of 0.549, according to the CEU (Utah residents with Northern and Western European ancestry from the CEPH collection), whereas it is a minor allele among CHB. Also, the prevalence of AMD seems to be lower among Chinese than Caucasian populations.23, 24, 25, 26 Therefore, the inconsistent association direction may be due to genetic heterogeneity and differences in population prevalence.
In addition to rs10033900, other common SNPs located within the CFI region have also been associated with AMD in several genome-wide association studies, including rs4698775,27 rs228571413 and rs7690921,12 although none of these SNPs occurs in high LD with rs10033900 (r2 ranges from 0.107 to 0.138 according to HapMap for CHB and JPT(Japanese in Tokyo, Japan)). Additionally, rs10033900 also seems to be independent of other common SNPs (r2<0.445) located in a LD block spanning 40 kb downstream to rs10033900 near the genes PLA2G12A and CASP6, whereas SNPs within the PLA2G12A locus have been correlated with rs10033900 in European populations.8, 20 Thus, it is unlikely that this variant represents a superior marker for causal variants in this AMD-susceptible region in Asians. Notably, the roles that rare CFI mutations have in the development of AMD were demonstrated in recent studies.28, 29 For example, van de Ven et al29 identified a rare, highly penetrant missense mutation c.355G>A (p.(Gly119Arg); RefSeq NM_000204.3) that confers a high risk of AMD (OR, 22.20; P=3.79 × 10−6) via the regulation of C3b degradation. Although this likely causal mutation was also identified by Seddon et al,28 the individual mutation showed no associations with AMD (P=0.24);28 instead, the burden of rare functional CFI variant enrichment in this gene was significantly increased in AMD cases (OR, 3.6; P=2.0 × 10−8), indicating the combined effects of multiple rare mutations on the modulation of AMD risk.28 Therefore, these rare variant studies have provided important implications for causal SNPs or mutations related to AMD in the Chinese population. However, no mutated alleles for c.355G>A (p.(Gly119Arg))29 were detected in 192 of our AMD cases (data were not shown). The sample sizes of such studies must be scaled up because these low-frequency variants are not easily detected. In addition, due to discrepancies in rare allelic architectures between Chinese and Caucasian populations, the same rare mutations found in Caucasians may not be replicated in Chinese cohorts. Thus, resequencing of the functional regions (eg, exons) of the CFI gene as well as the downstream region (eg, PLA2G12A) would help to better identify causal variants contributing to AMD susceptibility.
References
Klein R, Cruickshanks KJ, Nash SD et al: The prevalence of age-related macular degeneration and associated risk factors. Arch Ophthalmol 2010; 128: 750–758.
Edwards AO, Ritter R 3rd, Abel KJ, Manning A, Panhuysen C, Farrer LA : Complement factor H polymorphism and age-related macular degeneration. Science 2005; 308: 421–424.
Haines JL, Hauser MA, Schmidt S et al: Complement factor H variant increases the risk of age-related macular degeneration. Science 2005; 308: 419–421.
Klein RJ, Zeiss C, Chew EY et al: Complement factor H polymorphism in age-related macular degeneration. Science 2005; 308: 385–389.
Gold B, Merriam JE, Zernant J et al: Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration. Nat Genet 2006; 38: 458–462.
Yates JR, Sepp T, Matharu BK et al: Complement C3 variant and the risk of age-related macular degeneration. N Engl J Med 2007; 357: 553–561.
Maller JB, Fagerness JA, Reynolds RC, Neale BM, Daly MJ, Seddon JM : Variation in complement factor 3 is associated with risk of age-related macular degeneration. Nat Genet 2007; 39: 1200–1201.
Fagerness JA, Maller JB, Neale BM, Reynolds RC, Daly MJ, Seddon JM : Variation near complement factor I is associated with risk of advanced AMD. Eur J Hum Genet 2009; 17: 100–104.
Klaver CC, Kliffen M, van Duijn CM et al: Genetic association of apolipoprotein E with age-related macular degeneration. Am J Hum Genet 1998; 63: 200–206.
Souied EH, Benlian P, Amouyel P et al: The epsilon4 allele of the apolipoprotein E gene as a potential protective factor for exudative age-related macular degeneration. Am J Ophthalmol 1998; 125: 353–359.
McKay GJ, Silvestri G, Chakravarthy U et al: Variations in apolipoprotein E frequency with age in a pooled analysis of a large group of older people. Am J Epidemiol 2011; 173: 1357–1364.
Neale BM, Fagerness J, Reynolds R et al: Genome-wide association study of advanced age-related macular degeneration identifies a role of the hepatic lipase gene (LIPC). Proc Natl Acad Sci USA 2010; 107: 7395–7400.
Chen W, Stambolian D, Edwards AO et al: Genetic variants near TIMP3 and high-density lipoprotein-associated loci influence susceptibility to age-related macular degeneration. Proc Natl Acad Sci USA 2010; 107: 7401–7406.
Yu Y, Bhangale TR, Fagerness J et al: Common variants near FRK/COL10A1 and VEGFA are associated with advanced age-related macular degeneration. Hum Mol Genet 2011; 20: 3699–3709.
Rivera A, Fisher SA, Fritsche LG et al: Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk. Hum Mol Genet 2005; 14: 3227–3236.
Jakobsdottir J, Conley YP, Weeks DE, Mah TS, Ferrell RE, Gorin MB : Susceptibility genes for age-related maculopathy on chromosome 10q26. Am J Hum Genet 2005; 77: 389–407.
Sobrin L, Ripke S, Yu Y et al: Heritability and genome-wide association study to assess genetic differences between advanced age-related macular degeneration subtypes. Ophthalmology 2012; 119: 1874–1885.
Kondo N, Bessho H, Honda S, Negi A : Additional evidence to support the role of a common variant near the complement factor I gene in susceptibility to age-related macular degeneration. Eur J Hum Genet 2010; 18: 634–635.
Cipriani V, Matharu BK, Khan JC et al: No evidence of association between complement factor I genetic variant rs10033900 and age-related macular degeneration. Eur J Hum Genet 2012; 20: 1–2, author reply 3.
Ennis S, Gibson J, Cree AJ, Collins A, Lotery AJ : Support for the involvement of complement factor I in age-related macular degeneration. Eur J Hum Genet 2010; 18: 15–16.
Faul F, Erdfelder E, Lang AG, Buchner A : G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 2007; 39: 175–191.
Wu PB, Gu H, Yang XF, Liu NP : [Association of single nucleotide polymorphism in complement factor I gene with age-related macular degeneration]. Zhonghua Yan Ke Za Zhi 2013; 49: 350–356.
Kawasaki R, Yasuda M, Song SJ et al: The prevalence of age-related macular degeneration in Asians: a systematic review and meta-analysis. Ophthalmology 2010; 117: 921–927.
Klein R, Klein BE, Knudtson MD et al: Prevalence of age-related macular degeneration in 4 racial/ethnic groups in the multi-ethnic study of atherosclerosis. Ophthalmology 2006; 113: 373–380.
Li Y, Xu L, Jonas JB, Yang H, Ma Y, Li J : Prevalence of age-related maculopathy in the adult population in China: the Beijing eye study. Am J Ophthalmol 2006; 142: 788–793.
Li Y, Xu L, Wang YX, You QS, Yang H, Jonas JB : Prevalence of age-related maculopathy in the adult population in China: the Beijing eye study. Am J Ophthalmol 2008; 146: 329.
Fritsche LG, Chen W, Schu M et al: Seven new loci associated with age-related macular degeneration. Nat Genet 2013; 45: 433–439, 439e1–439e2.
Seddon JM, Yu Y, Miller EC et al: Rare variants in CFI, C3 and C9 are associated with high risk of advanced age-related macular degeneration. Nat Genet 2013; 45: 1366–1370.
van de Ven JP, Nilsson SC, Tan PL et al: A functional variant in the CFI gene confers a high risk of age-related macular degeneration. Nat Genet 2013; 45: 813–817.
Acknowledgements
This work was supported by the 973 Program (2011CB504000), the National Natural Science Foundation of China (31200954), the Wu Jieping Medical Foundation (320.67001118) and the China Postdoctoral Science Foundation (2012M510110, 2012M520886, 2013M541513, 2013T60440).
DATA SUBMISSION
The data in this manuscript have been submitted to public database GWAS Central (https://www.gwascentral.org/) and the study ID is HGVST1714.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Qian, D., Kan, M., Weng, X. et al. Common variant rs10033900 near the complement factor I gene is associated with age-related macular degeneration risk in Han Chinese population. Eur J Hum Genet 22, 1417–1419 (2014). https://doi.org/10.1038/ejhg.2014.37
Published:
Issue Date:
DOI: https://doi.org/10.1038/ejhg.2014.37
This article is cited by
-
Association of polymorphisms of complement factor I rs141853578 (G119R) with age-related macular degeneration in Iranian population
International Ophthalmology (2019)